1. Home
  2. LMAT vs TMDX Comparison

LMAT vs TMDX Comparison

Compare LMAT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$95.59

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$72.26

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
TMDX
Founded
1983
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
LMAT
TMDX
Price
$95.59
$72.26
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$105.80
$148.22
AVG Volume (30 Days)
303.1K
969.8K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
0.93%
N/A
EPS Growth
30.57
382.18
EPS
0.68
0.20
Revenue
$249,602,000.00
$605,494,000.00
Revenue This Year
$14.21
$24.25
Revenue Next Year
$8.88
$18.75
P/E Ratio
$143.37
$355.65
Revenue Growth
13.53
37.13
52 Week Low
$79.01
$60.11
52 Week High
$118.01
$156.00

Technical Indicators

Market Signals
Indicator
LMAT
TMDX
Relative Strength Index (RSI) 42.33 47.33
Support Level $95.47 $64.87
Resistance Level $97.83 $79.60
Average True Range (ATR) 3.46 3.13
MACD -0.58 0.02
Stochastic Oscillator 2.30 34.57

Price Performance

Historical Comparison
LMAT
TMDX

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: